LRRC8D

gene
On this page

Also known as FLJ10470

Summary

LRRC8D (leucine rich repeat containing 8 VRAC subunit D, HGNC:16992) is a protein-coding gene on chromosome 1p22.2, encoding Volume-regulated anion channel subunit LRRC8D (Q7L1W4). Non-essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes.

Enables volume-sensitive anion channel activity. Involved in several processes, including monoatomic anion transmembrane transport; organic acid transmembrane transport; and protein hexamerization. Located in cytoplasm and plasma membrane. Part of monoatomic ion channel complex.

Source: NCBI Gene 55144 — RefSeq curated summary.

At a glance

  • GWAS associations: 7
  • Clinical variants (ClinVar): 73 total
  • MANE Select transcript: NM_001134479

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16992
Approved symbolLRRC8D
Nameleucine rich repeat containing 8 VRAC subunit D
Location1p22.2
Locus typegene with protein product
StatusApproved
AliasesFLJ10470
Ensembl geneENSG00000171492
Ensembl biotypeprotein_coding
OMIM612890
Entrez55144

Gene structure

Transcript identifiers

Ensembl transcripts: 37 — 37 protein_coding

ENST00000337338, ENST00000394593, ENST00000414841, ENST00000441269, ENST00000525774, ENST00000527156, ENST00000532201, ENST00000906496, ENST00000906497, ENST00000906498, ENST00000906499, ENST00000906500, ENST00000906501, ENST00000906502, ENST00000906503, ENST00000906504, ENST00000906505, ENST00000906506, ENST00000906507, ENST00000906508, ENST00000906509, ENST00000906510, ENST00000906512, ENST00000906513, ENST00000906514, ENST00000906516, ENST00000906518, ENST00000906519, ENST00000906520, ENST00000906521, ENST00000932575, ENST00000932576, ENST00000932577, ENST00000947385, ENST00000947386, ENST00000947387, ENST00000947388

RefSeq mRNA: 2 — MANE Select: NM_001134479 NM_001134479, NM_018103

CCDS: CCDS726

Canonical transcript exons

ENST00000337338 — 3 exons

ExonStartEnd
ENSE000012119458982103289821291
ENSE000016011308993306789936611
ENSE000036366668984363889843782

Expression profiles

Bgee: expression breadth ubiquitous, 285 present calls, max score 98.06.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.6751 / max 325.6449, expressed in 1815 samples.

FANTOM5 promoters (11 alternative TSS)

Promoter IDTPM avgSamples expressed
397915.78691700
39873.78491309
39782.33251127
39880.8485507
39830.3238143
39820.2587132
39850.104154
39800.097826
39840.069833
39810.047811

Top tissues by expression

288 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
inferior vagus X ganglionUBERON:000536398.06gold quality
subthalamic nucleusUBERON:000190697.84gold quality
trigeminal ganglionUBERON:000167597.18gold quality
lateral globus pallidusUBERON:000247697.06gold quality
medulla oblongataUBERON:000189697.04gold quality
dorsal plus ventral thalamusUBERON:000189796.94gold quality
superior vestibular nucleusUBERON:000722796.81gold quality
corpus callosumUBERON:000233696.76gold quality
ventral tegmental areaUBERON:000269196.75gold quality
gingival epitheliumUBERON:000194996.51gold quality
CA1 field of hippocampusUBERON:000388196.37gold quality
inferior olivary complexUBERON:000212796.26gold quality
substantia nigra pars reticulataUBERON:000196696.18gold quality
dorsal root ganglionUBERON:000004496.08gold quality
ponsUBERON:000098896.06gold quality
lateral nuclear group of thalamusUBERON:000273695.74gold quality
substantia nigra pars compactaUBERON:000196595.65gold quality
secondary oocyteCL:000065595.11gold quality
epithelium of nasopharynxUBERON:000195194.87gold quality
nasal cavity epitheliumUBERON:000538494.81gold quality
germinal epithelium of ovaryUBERON:000130494.79gold quality
Brodmann (1909) area 46UBERON:000648394.65gold quality
olfactory bulbUBERON:000226494.49gold quality
gingivaUBERON:000182894.48gold quality
dorsal motor nucleus of vagus nerveUBERON:000287094.39gold quality
jejunal mucosaUBERON:000039994.32gold quality
orbitofrontal cortexUBERON:000416794.15gold quality
monocyteCL:000057694.11gold quality
mononuclear cellCL:000084294.10gold quality
leukocyteCL:000073893.87gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.72

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

68 targeting LRRC8D, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-126-5P100.0072.713180
HSA-MIR-3163100.0077.238605
HSA-MIR-4262100.0073.263931
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-428299.9975.366408
HSA-MIR-366299.9973.825684
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-32-5P99.9875.211964
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-25-3P99.9874.601817
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-569699.9872.364487
HSA-MIR-365899.9673.874379
HSA-MIR-545-3P99.9570.742783
HSA-MIR-205-3P99.9269.923165
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-806299.8868.43995
HSA-MIR-450399.8571.451869
HSA-MIR-313399.8170.923506

Literature-anchored findings (GeneRIF, showing 3)

  • identified four genes, named TA-LRRP, AD158, LRRC5, and FLJ23420, as unknown LRRC8-like genes (PMID:15094057)
  • LRRC8D is a target gene of the BACH1 transcription factor according to ChIP-seq analysis in HEK 293 cells. (PMID:21555518)
  • Cryo-EM structure of the volume-regulated anion channel LRRC8D isoform identifies features important for substrate permeation. (PMID:32415200)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriolrrc8dbENSDARG00000103840
mus_musculusLrrc8dENSMUSG00000046079
rattus_norvegicusLrrc8dENSRNOG00000002121

Paralogs (31): LRRC7 (ENSG00000033122), PHLPP2 (ENSG00000040199), LRRC40 (ENSG00000066557), LRCH4 (ENSG00000077454), PHLPP1 (ENSG00000081913), SHOC2 (ENSG00000108061), ERBIN (ENSG00000112851), LRRC39 (ENSG00000122477), LRCH2 (ENSG00000130224), LRCH1 (ENSG00000136141), LRRC8A (ENSG00000136802), LRRC1 (ENSG00000137269), MFHAS1 (ENSG00000147324), LRRC27 (ENSG00000148814), LRRK1 (ENSG00000154237), LRRC58 (ENSG00000163428), LRRC2 (ENSG00000163827), LRRC18 (ENSG00000165383), LRRC28 (ENSG00000168904), LRRC8E (ENSG00000171017), LRRC8C (ENSG00000171488), PIDD1 (ENSG00000177595), SCRIB (ENSG00000180900), LRCH3 (ENSG00000186001), LRRIQ4 (ENSG00000188306), LRRC8B (ENSG00000197147), LRRC10 (ENSG00000198812), LRRC10B (ENSG00000204950), LRRC30 (ENSG00000206422), LRRC69 (ENSG00000214954), LRRD1 (ENSG00000240720)

Protein

Protein identifiers

Volume-regulated anion channel subunit LRRC8DQ7L1W4 (reviewed: Q7L1W4)

Alternative names: Leucine-rich repeat-containing protein 5, Leucine-rich repeat-containing protein 8D

All UniProt accessions (6): Q7L1W4, E9PJ89, E9PJS7, E9PL08, E9PMF9, Q5VWA0

UniProt curated annotations — full annotation on UniProt →

Function. Non-essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes. The VRAC channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine. Plays a redundant role in the efflux of amino acids, such as aspartate, in response to osmotic stress. LRRC8A and LRRC8D are required for the uptake of the drug cisplatin. Channel activity requires LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channel characteristics depend on the precise subunit composition. Also acts as a regulator of glucose-sensing in pancreatic beta cells: VRAC currents, generated in response to hypotonicity- or glucose-induced beta cell swelling, depolarize cells, thereby causing electrical excitation, leading to increase glucose sensitivity and insulin secretion. VRAC channels containing LRRC8D inhibit transport of immunoreactive cyclic dinucleotide GMP-AMP (2’-3’-cGAMP), an immune messenger produced in response to DNA virus in the cytosol. Mediates the import of the antibiotic blasticidin-S into the cell.

Subunit / interactions. Heterohexamer; oligomerizes with other LRRC8 proteins (LRRC8A, LRRC8B, LRRC8C and/or LRRC8E) to form a heterohexamer. In vivo, the subunit composition may depend primarily on expression levels, and heterooligomeric channels containing various proportions of the different LRRC8 proteins may coexist.

Subcellular location. Cell membrane. Endoplasmic reticulum membrane.

Domain organisation. The volume-regulated anion channel (VRAC) channel forms a trimer of dimers, with symmetry mismatch between the pore-forming domain and the cytosolic LRR repeats, a topology similar to gap junction proteins.

Similarity. Belongs to the LRRC8 family.

RefSeq proteins (2): NP_001127951, NP_060573 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001611Leu-rich_rptRepeat
IPR003591Leu-rich_rpt_typical-subtypRepeat
IPR021040LRRC8_Pannexin-likeDomain
IPR032675LRR_dom_sfHomologous_superfamily
IPR050216LRR_domain-containingFamily

Pfam: PF12534, PF13855

Catalyzed reactions (Rhea), 3 shown:

  • chloride(in) = chloride(out) (RHEA:29823)
  • iodide(out) = iodide(in) (RHEA:66324)
  • taurine(out) = taurine(in) (RHEA:66328)

UniProt features (32 total): repeat 13, topological domain 5, transmembrane region 4, modified residue 3, mutagenesis site 2, chain 1, region of interest 1, compositionally biased region 1, disulfide bond 1, sequence variant 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
6M04ELECTRON MICROSCOPY4.36

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7L1W4-F181.500.54

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 241, 242, 246

Disulfide bonds (1): 54–354

Mutagenesis-validated functional residues (2):

PositionPhenotype
44alters channel anion selectivity.
143affects ion selectivity of the channel. reduced permeability to negatively charged glutamate and gluconate.

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-5223345Miscellaneous transport and binding events
R-HSA-382551Transport of small molecules

MSigDB gene sets: 232 (showing top): GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, RNGTGGGC_UNKNOWN, TTTGTAG_MIR520D, AREB6_03, GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT, GOBP_NUCLEOTIDE_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT, GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT, GOBP_AMINO_ACID_TRANSPORT, GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_SULFUR_COMPOUND_TRANSPORT, AAAGGGA_MIR204_MIR211, GOBP_DICARBOXYLIC_ACID_TRANSPORT

GO Biological Process (8): intracellular glucose homeostasis (GO:0001678), taurine transmembrane transport (GO:0015734), aspartate transmembrane transport (GO:0015810), protein hexamerization (GO:0034214), cellular response to osmotic stress (GO:0071470), monoatomic anion transmembrane transport (GO:0098656), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220)

GO Molecular Function (2): volume-sensitive anion channel activity (GO:0005225), protein binding (GO:0005515)

GO Cellular Component (6): cytoplasm (GO:0005737), endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), membrane (GO:0016020), monoatomic ion channel complex (GO:0034702), endoplasmic reticulum (GO:0005783)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Transport of small molecules1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nitrogen compound transport2
cellular anatomical structure2
glucose homeostasis1
intracellular chemical homeostasis1
alkanesulfonate transmembrane transport1
amino acid transmembrane transport1
C4-dicarboxylate transport1
acidic amino acid transport1
carboxylic acid transmembrane transport1
protein complex oligomerization1
response to osmotic stress1
cellular response to chemical stress1
cellular response to abiotic stimulus1
monoatomic anion transport1
monoatomic ion transmembrane transport1
transport1
monoatomic ion transport1
transmembrane transport1
monoatomic anion channel activity1
binding1
intracellular anatomical structure1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
membrane1
cell periphery1
transmembrane transporter complex1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

1048 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LRRC8DPCSK4Q6UW60629
LRRC8DTTYH2Q9BSA4575
LRRC8DBEST1O76090552
LRRC8DCLCN3P51790547
LRRC8DCTSWP56202513
LRRC8DKCPQ6ZWJ8510
LRRC8DTTYH3Q9C0H2502
LRRC8DTTYH1Q9H313494
LRRC8DIHHQ14623473
LRRC8DTNFRSF18Q9Y5U5469
LRRC8DCFTRP13569451
LRRC8DHEPACAMQ14CZ8447
LRRC8DCLCA4Q14CN2447
LRRC8DCLCA2Q9UQC9446
LRRC8DANO1Q5XXA6436

IntAct

31 interactions, top by confidence:

ABTypeScore
LRRC8BSLC25A17psi-mi:“MI:0914”(association)0.530
LRRC8DLRRC8Dpsi-mi:“MI:0915”(physical association)0.490
LRRC8ALRRC8Dpsi-mi:“MI:0915”(physical association)0.400
SLC17A2PSMD11psi-mi:“MI:0914”(association)0.350
HTR3AGPAA1psi-mi:“MI:0914”(association)0.350
NS3C15orf61psi-mi:“MI:0914”(association)0.350
NBASpsi-mi:“MI:0914”(association)0.350
SHTN1psi-mi:“MI:0914”(association)0.350
TMEM223psi-mi:“MI:0914”(association)0.350
SHANK3IGKV3D-15psi-mi:“MI:0914”(association)0.350
SHANK3ELAVL2psi-mi:“MI:0914”(association)0.350
TTYH1TMEM223psi-mi:“MI:0914”(association)0.350
CHRNA4TMEM223psi-mi:“MI:0914”(association)0.350
HCSTTMEM120Bpsi-mi:“MI:0914”(association)0.350
SIDT2KLRG2psi-mi:“MI:0914”(association)0.350
RXFP1UPK3BL1psi-mi:“MI:0914”(association)0.350
NKAIN1GPR89Apsi-mi:“MI:0914”(association)0.350
SLC17A2ABCD4psi-mi:“MI:0914”(association)0.350
OR10H2ABCD4psi-mi:“MI:0914”(association)0.350
HTR3AEXTL3psi-mi:“MI:0914”(association)0.350
NPEPPSKIF5Bpsi-mi:“MI:0914”(association)0.350
OR2H2SERPINB8psi-mi:“MI:0914”(association)0.350
LRRC8BCDH2psi-mi:“MI:0914”(association)0.350
SLC22A14CLGNpsi-mi:“MI:0914”(association)0.350
SLC44A1UPK3BL1psi-mi:“MI:0914”(association)0.350
SLC44A5UPK3BL1psi-mi:“MI:0914”(association)0.350
EXOSC4LRRC8Dpsi-mi:“MI:0915”(physical association)0.000

BioGRID (60): LRRC8D (Reconstituted Complex), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-RNA), LRRC8D (Affinity Capture-RNA), LRRC8D (Affinity Capture-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Affinity Capture-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS), LRRC8D (Proximity Label-MS)

ESM2 similar proteins: A0JPH4, A2AHL1, A8DZH4, D3ZWZ9, E7FFT2, F1QFU0, F1QZE9, P48763, P50482, P86044, Q28CV2, Q32NZ6, Q3TPR7, Q3ZAS0, Q4R7U0, Q4V8U5, Q5F3F5, Q5M7W4, Q5RH73, Q5YCC5, Q5ZKN3, Q68DH5, Q6GQE1, Q6P4P2, Q6UXY8, Q7L1W4, Q7Z2W7, Q7Z402, Q7ZYA0, Q810F5, Q8BH79, Q8C428, Q8C561, Q8CB19, Q8IZK6, Q8N3S3, Q8R455, Q8R4D5, Q8R4P4, Q8R4P5

Diamond homologs: A5PK13, Q3KRC6, Q498T9, Q4V8I7, Q5DU41, Q5U308, Q66JT1, Q68F79, Q6NSJ5, Q6NU09, Q6P9F7, Q7L1W4, Q80WG5, Q8BGR2, Q8IWT6, Q8R502, Q8TDW0, A6NIV6, Q9Z1S7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

73 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance68
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1483 predictions. Top by Δscore:

VariantEffectΔscore
1:89933066:GGAAT:Gacceptor_gain1.0000
1:89846515:A:AGacceptor_gain0.9900
1:89846516:G:GGacceptor_gain0.9900
1:89933061:TTCTA:Tacceptor_loss0.9900
1:89933062:TCTA:Tacceptor_loss0.9900
1:89933062:TCTAG:Tacceptor_loss0.9900
1:89933063:CTAG:Cacceptor_loss0.9900
1:89933063:CTAGG:Cacceptor_loss0.9900
1:89933064:TA:Tacceptor_loss0.9900
1:89933064:TAGG:Tacceptor_loss0.9900
1:89933065:A:AGacceptor_gain0.9900
1:89933065:AG:Aacceptor_gain0.9900
1:89933065:AGG:Aacceptor_loss0.9900
1:89933065:AGGA:Aacceptor_loss0.9900
1:89933066:G:Aacceptor_loss0.9900
1:89933066:G:Cacceptor_loss0.9900
1:89933066:G:GGacceptor_gain0.9900
1:89933066:GG:Gacceptor_gain0.9900
1:89933066:GGA:Gacceptor_gain0.9900
1:89846515:AGTCT:Aacceptor_gain0.9800
1:89846516:GTCTG:Gacceptor_gain0.9800
1:89895391:C:Gdonor_gain0.9800
1:89933066:GGAA:Gacceptor_gain0.9800
1:89821288:CAAG:Cdonor_loss0.9700
1:89821289:AAG:Adonor_loss0.9700
1:89821290:AG:Adonor_loss0.9700
1:89821291:GG:Gdonor_loss0.9700
1:89821292:G:GCdonor_loss0.9700
1:89821293:T:Gdonor_loss0.9700
1:89846516:GTCT:Gacceptor_gain0.9700

AlphaMissense

5730 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:89933138:T:AW24R1.000
1:89933138:T:CW24R1.000
1:89933228:T:CC54R1.000
1:89933230:T:GC54W1.000
1:89933527:T:GC153W1.000
1:89933690:T:AW208R1.000
1:89933690:T:CW208R1.000
1:89933692:G:CW208C1.000
1:89933692:G:TW208C1.000
1:89934128:T:AC354S1.000
1:89934128:T:CC354R1.000
1:89934129:G:CC354S1.000
1:89934130:C:GC354W1.000
1:89934377:T:CF437L1.000
1:89934379:C:AF437L1.000
1:89934379:C:GF437L1.000
1:89934405:T:CL446P1.000
1:89934731:T:AW555R1.000
1:89934731:T:CW555R1.000
1:89933140:G:CW24C0.999
1:89933140:G:TW24C0.999
1:89933228:T:AC54S0.999
1:89933229:G:AC54Y0.999
1:89933229:G:CC54S0.999
1:89933525:T:AC153S0.999
1:89933525:T:CC153R0.999
1:89933526:G:AC153Y0.999
1:89933526:G:CC153S0.999
1:89933526:G:TC153F0.999
1:89933615:T:AW183R0.999

dbSNP variants (sampled 300 via entrez): RS1000025483 (1:89821379 C>G), RS1000037636 (1:89864004 A>G), RS1000053139 (1:89877600 G>A), RS1000056223 (1:89906691 A>G), RS1000056682 (1:89821482 T>G), RS1000061123 (1:89841439 C>T), RS1000140670 (1:89890333 C>G), RS1000142680 (1:89928394 A>G), RS1000151720 (1:89855914 A>C), RS1000167531 (1:89846051 T>G), RS1000274733 (1:89921695 C>T), RS1000309603 (1:89883452 T>C), RS1000319902 (1:89840153 G>A), RS1000409975 (1:89846631 T>G), RS1000427376 (1:89919497 A>G)

Disease associations

OMIM: gene MIM:612890 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

7 associations (top):

StudyTraitp-value
GCST002774_1Cognitive function3.000000e-06
GCST003434_11Obsessive-compulsive symptoms8.000000e-06
GCST004748_70Lung cancer4.000000e-06
GCST004750_98Squamous cell lung carcinoma1.000000e-06
GCST006210_1Thiopurine-induced digestive symptoms in inflammatory bowel disease7.000000e-07
GCST90002395_312Mean platelet volume6.000000e-12
GCST90002395_313Mean platelet volume4.000000e-13

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004337intelligence
EFO:0007802obsessive-compulsive symptom measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

50 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Tobacco Smoke Pollutiondecreases expression, decreases methylation, increases expression3
bisphenol Aaffects cotreatment, decreases methylation, decreases expression2
sodium arsenitedecreases expression, increases expression2
Estradioldecreases expression, affects cotreatment2
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression2
Cyclosporineincreases expression2
aristolochic acid Idecreases expression1
GSK-J4increases expression1
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
pirinixic aciddecreases expression, increases activity, affects binding1
cobaltous chloridedecreases expression1
benzo(e)pyreneincreases methylation1
potassium chromate(VI)affects cotreatment, decreases expression1
ferrous chloridedecreases expression1
resorcinoldecreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
avobenzonedecreases expression1
di-n-butylphosphoric acidaffects expression1
perfluoro-n-nonanoic acidincreases expression1
monomethylarsonous aciddecreases expression1
abrinedecreases expression1
prothioconazoleincreases expression1
Temozolomideincreases expression1
Sunitinibincreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Leflunomideincreases expression1
Acetaminophendecreases expression1
Air Pollutantsaffects expression, increases abundance1
Vehicle Emissionsdecreases methylation1

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_SV96HAP1 LRRC8D (-) 1Cancer cell lineMale
CVCL_SV97HAP1 LRRC8D (-) 2Cancer cell lineMale
CVCL_SV98HAP1 LRRC8D (-) 3Cancer cell lineMale
CVCL_SV99HAP1 LRRC8D (-) 4Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.